Efficacy of Tirbanibulin 1% Beyond Complete Clearance (CC): Percent Reduction of Actinic Keratosis (AK) Lesions as a Clinically Meaningful Endpoint

tirbanibulin oral (KX-01 oral) - Athenex

https://eposters.aad.org/abstracts/76748

Neal Bhatia; Julia Welzel; Yolanda Gilaberte; Carola Berking; Paul Tomondy; Raidah Salem; Laura Padullés; Andrew Blauvelt

Mar 12, 2026